XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss, including amounts attributable to noncontrolling interest $ (14,346) $ (390,462)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Stock-based compensation expense 139,263 120,032
Change in fair value of acquisition related contingent consideration 3,750 0
Charitable donation of common stock 8,871 8,025
Amortization of intangible assets 5,931 1,646
Depreciation expense 2,361 3,329
Amortization of deferred contract acquisition costs 35,650 31,066
Loss from equity method investment 0 3,048
Net amortization of premiums or discounts on short-term investments (12,933) (14,361)
Unrealized foreign exchange loss (gain), net (5,442) 252
Other non-cash expense, net 768 317
Changes in assets and liabilities:    
Accounts receivable (31,658) (5,291)
Prepaid expenses and other current assets 2,498 (8,183)
Deferred contract acquisition costs (35,706) (31,760)
Other non-current assets 851 (1,174)
Accounts payable 33 (224)
Accrued expenses and other current liabilities (241,704) 245,857
Accrued compensation and benefits (8,815) 2,842
Deferred revenue 34,503 29,158
Other non-current liabilities (11,068) 16,070
Net cash provided by (used in) operating activities (127,193) 10,187
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of short-term investments (503,394) (573,676)
Proceeds from maturities of short-term investments 524,862 526,979
Purchases of property and equipment (2,608) (1,269)
Payments for business combination, net of cash acquired (20,210) 0
Payments for asset acquisition (7,660) 0
Escrow payment related to business combination, after acquisition date 0 (2,500)
Other investing activities 457 0
Net cash used in investing activities (8,553) (50,466)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases 17,895 22,492
Issuance of common stock under employee stock purchase plan 7,932 7,751
Settlement of acquisition related contingent cash consideration (4,900) 0
Net cash provided by financing activities 20,927 30,243
Impact of foreign exchange on cash and cash equivalents 3,455 (2,557)
Net decrease in cash and cash equivalents (111,364) (12,593)
Cash and cash equivalents at beginning of period 287,996 297,902
Cash and cash equivalents at end of period 176,632 285,309
Supplemental disclosure of cash flow information:    
Cash paid for income taxes related to the bilateral advance pricing agreement 187,735 0
Other cash paid for income taxes 2,585 6,015
Supplemental disclosure of non-cash investing and financing activities:    
Vesting of early exercised stock options 267 1,030
Unpaid property and equipment in accounts payable $ 377 $ 68